GGrantIndex
← Search

ADIPOSITY, NUCLEAR HORMONE SIGNALING, AND THE RESPONSE PHENOTYPE TO ANDROGEN SIGNALING INHIBITION IN METASTATIC PROSTATE CANCER

$484,600FY2022Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →
ADIPOSITY, NUCLEAR HORMONE SIGNALING, AND THE RESPONSE PHENOTYPE TO ANDROGEN SIGNALING INHIBITION IN METASTATIC PROSTATE CANCER · GrantIndex